Cover Image

Quality by Design‐Based Development of a Robust LC Method for Simultaneous Estimation of Process‐ and Degradation‐Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Siva Prasad Korikana, Sreenivasa Rao Battula, Naresh Konduru, Aravind Kurnool, Divya Kumar Vemuri, Venkata Lakshamana Sagar Dantinapalli
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Biomedical Chromatography
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design
by: Fei Han, et al.
Published: (2025)

Multiple Reaction Monitoring LC‐MS/MS Quantification of N‐Nitrosamine Drug Substance Related Impurities of Clonidine in Drug Substance and in Tablet Dosage Form
by: Bhaskar Vallamkonda, et al.
Published: (2025)

Characterization and Analytical Method Validation for Potential Impurities of a Merchantability Drug Substance Fluoxetine HCl
by: Rajani Reddy Janna Reddy, et al.
Published: (2025)

Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method
by: Babu Reddy Goguladinne, et al.
Published: (2025)

Comprehensive Impurity and Degradation Profiling of Iptacopan Using a White–Green Stability‐Indicating HPLC Method Coupled With LC–MS/MS and In Silico Toxicity Evaluation
by: Satyanarayana Reddy Jaggavarapu, et al.
Published: (2026)

Novel Genotoxic Impurities in the First‐Line Oral Anticoagulant Drug, Apixaban: Computational Toxicological Evaluation and Development of a Highly Sensitive LC‐MS/MS Quantification Method
by: Bhaskar Vallamkonda, et al.
Published: (2025)

Bioanalytical Tandem Mass Spectrometry Method for Precise Measurement of Tranexamic Acid in Human Plasma With Unveiling Methodological Advancement: Green Assessment With Advanced Metrics
by: Anil Kollapareddy, et al.
Published: (2025)

Simultaneous Determination of Atezolizumab and Bevacizumab by LC–MS/MS in Rat Plasma and Its Application to a Pharmacokinetic Study
by: Sudha Divya Madhuri Kallam, et al.
Published: (2025)

Development of a Stability‐Indicating HPLC Method for Quantification of Belzutifan and Its Related Impurities With LC–MS/MS Characterization of Degradation Products
by: Pydi Simhachalam, et al.
Published: (2025)

Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
by: Rajeshwari Dandabattina, et al.
Published: (2025)

Estimation of Antimicrobial Agent (Sorbic Acid) in Semisolid Dosage Form (Gel) Using Liquid Chromatography and Evaluation of Its Stability in the Presence of Steroids, Polymers, and Low pH
by: Naresh Konduru, et al.
Published: (2026)

High‐Sensitivity LC‐MS/MS Approach for Accurate Quantification of N‐Nitroso Duloxetine in Duloxetine Pharmaceutical Formulations
by: Syam Sundhar Sai Kumar Boppana, et al.
Published: (2025)

Development and Validation of an RP‐HPLC Method for Organic Impurity Profiling in Baclofen Utilizing Robustness Through a Quality‐by‐Design (QbD) Approach: A Comprehensive Forced Degradation Assessment
by: Santhosh Kumar Ettaboina, et al.
Published: (2025)

A Robust LC‐MS/MS Bioanalytical Strategy for Simultaneous Quantification of Tramadol HCl and Dexketoprofen Trometamol and Its Use in Pharmacokinetic Studies
by: Adusumalli Srinivasa Rao, et al.
Published: (2026)

A selective, sensitive and fast LC–MS/MS method for cabotegravir quantification in rat plasma and pharmacokinetic investigations
by: Bandaru Venkata Ramarao, et al.
Published: (2024)

From Separation to Safety Prediction: Validated RP‐HPLC Method for Simultaneous Estimation of Sitagliptin and Lobeglitazone, LC‐MS/MS Identification of Degradant Products, and In Silico Safety Profiling
by: Rutvi Patel, et al.
Published: (2025)

In Silico Assessment and Quantitative Estimation of Potential Toxic Impurities From Propafenone (PFN) Through Generic Route and Using UPLC‐MS/MS Technique
by: Nishtala Venkata Bharat, et al.
Published: (2025)

Validated GC–MS and LC–MS/MS Methods for ICH M7–Based Quantification of Alkyl Mesylate and Azido Genotoxic Impurities in Pharmaceutical Products
by: Neşet Neşetoğlu, et al.
Published: (2026)

UHPLC Method Development for the Trace Level Quantification of Anastrozole and Its Process‐Related Impurities Using Design of Experiments
by: Narasimha Rao Tadisetty, et al.
Published: (2025)

Validation of a LC‐MS/MS Assay for Rapid and Simultaneous Quantification of Cobicistat and Venetoclax in Human Plasma and Serum
by: Niels Westra, et al.
Published: (2025)

Simultaneous Determination of Buspirone, Alprazolam, Clonazepam, Diazepam, and Lorazepam by LC‐MS/MS: Evaluation of Greenness Using AGREE Tool
by: Aykut Kul, et al.
Published: (2025)

Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone
by: Santhosh Kumar Ettaboina, et al.
Published: (2024)

Determination of 59 Psychotropic Drugs, Including Antipsychotics, Antidepressants, Antiepileptics, Anti‐Alcohol Abuse Drugs, Anti‐ADHD Drugs, and Their Metabolites in Urine Using LC–MS/MS for Medication Compliance Monitoring
by: Jeong Eun Kim, et al.
Published: (2025)

Development and Validation of the Novel, Fast Bioanalytical LC‐MS/MS Technique for the Simultaneous Estimation of Sotorasib and Ondansetron: Application to In Vivo Pharmacokinetic Assessments
by: Jony Susanna Kandula, et al.
Published: (2026)

Development and Validation of a Stability‐Indicating LC Method for the Determination of Empagliflozin‐Related Substances With Sensitivity Profiling and Robustness Assessment Using Analytical Quality by Design Principles
by: Siva Prasad Korikana, et al.
Published: (2026)

Automated LC–MS/MS Data Reporting Workflow Using mzML and R for Urine Drug Screening and Quantitative Confirmation
by: Nam Hee Kwon, et al.
Published: (2026)

Simultaneous Quantification of Caffeic and Ferulic Acids by HPLC‐UV in Nanoparticles: Degradation Profiling and Computational Peroxidation Analysis
by: Igor Roesch Felix, et al.
Published: (2025)

Quality by Design‐Based Stability‐Indicating RP‐HPLC Method for Diminazene Diaceturate in Veterinary Formulation Supported by LC–MS Characterization of Degradation Products
by: Sumedha V. Shetye, et al.
Published: (2026)

A Simple, Sensitive, and Stable LC–MS/MS Method for the Simultaneous Determination and Pharmacokinetic Study of Dapagliflozin and Its Metabolite D3OG in Human Plasma
by: Ancheng Gu, et al.
Published: (2025)

Separation and Identification of Impurity of Chlortetracycline Hydrochloride Not Included in the European Pharmacopoeia
by: Xi Chen, et al.
Published: (2026)

LC–MS/MS Assay for Simultaneous Quantification of Dual‐Targeting 1,5‐Diaryl‐1,2,4‐Triazole Sulfonamides (WA11–13) in Human Plasma
by: Fawzy A. Elbarbry, et al.
Published: (2025)

A Validated, Stability‐Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance
by: Lixiang Zhang, et al.
Published: (2025)

Stress‐Induced Structural Divergence of Selpercatinib, a RET Inhibitor: Application of HRMS and NMR for the Discovery of Unique Degradation Products
by: Sai Ram Prasad Kollu, et al.
Published: (2025)

Quantitation of Niraparib in Human Plasma by LC‐MS/MS
by: Tien V. Le, et al.
Published: (2025)

Multidimensional and Hybrid Separation Strategies for Body Fluids and Tissues: Comparative Performance and Translational Considerations
by: Uttam Prasad Panigrahy, et al.
Published: (2026)

LC–MS/MS method for the quantification of cortisol of hepatocellular carcinoma
by: Zijing Zhou, et al.
Published: (2024)

Correction to “A LC–MS/MS Method for the Simultaneous Determination of 6‐Cyanodopamine, 6‐Nitrodopamine, 6‐Nitrodopa, 6‐Nitroadrenaline and 6‐Bromodopamine in Human Plasma and Its Clinical Application in Patients With Chronic Kidney Disease”
Published: (2025)

A Buffered LC‐MS Method for Resolving and Quantifying Albiflorin and Paeoniflorin
by: Alina Gazizova, et al.
Published: (2026)

Stability‐Indicating RP‐HPLC Method Development and Validation for Determination of Impurities in Loperamide Hydrochloride Capsules Dosage Form
by: Sreenivas Pippalla, et al.
Published: (2025)

LC–MS/MS determination of N‐acetyl‐l‐cysteine in chicken plasma
by: Albena Roydeva, et al.
Published: (2024)